Nirsevimab protects infants against RSV-linked hospitalization
by Elana GotkineNirsevimab is efficacious for preventing hospitalization for respiratory syncytial virus (RSV)-associated lower respiratory tract infection among infants, according to a study publishe
Updated on: February 29,2024
18
Nirsevimab protects infants against RSV-linked hospitalization
by Elana GotkineNirsevimab is efficacious for preventing hospitalization for respiratory syncytial virus (RSV)-associated lower respiratory tract infection among infants, according to a study publishe
Updated on:February 29,2024
18
